October 10, 2010

Johnson & Johnson is set to buy the remaining portion of Dutch biotech company Crucell...

October 6, 2010

Relatively healthy patients with Type 2 diabetes experienced a significant reduction in blood-sugar levels when...

October 4, 2010

Human Genome Sciences and Novartis have decided not to further develop an investigative biologic treatment...

September 29, 2010

The Food and Drug Administration declined to approve a Teva biosimilar, the generic drug maker...

September 28, 2010

The drug market for Crohn's disease treatments will see moderate growth over the next decade,...

September 28, 2010

While biosimilars promise to provide therapies for a wide range of diseases, their biggest fans...

September 27, 2010

Endo Pharmaceuticals will acquire generic drug maker Qualitest Pharmaceuticals for $1.2 billion, Endo said Tuesday....

September 26, 2010

Biosimilars, biogenerics, follow-on biologics—whatever the designation one prefers for knockoffs of biotech drugs—they will soon...

September 26, 2010

The generics subsidiary of Pfizer is launching a new business focused on authorized generics. Greenstone...

September 26, 2010

Many generic drug companies have long marketed branded drugs on the side, but lately, some...

September 26, 2010

For all its successes, the generic drug industry has had a lot to worry about...

September 8, 2010

Hi-Tech Pharmacal had $40.4 million in sales during its fiscal first quarter ended July 31,...

September 7, 2010

Swiss drug maker Lonza will help British drug maker GlaxoSmithKline manufacture five biotech drugs in...

August 29, 2010

AstraZeneca's biologics unit has received a second complete response letter from the Food and Drug...

August 23, 2010

French drug maker Sanofi-Aventis is suing to stop Sandoz’ generic version of its blood thinner...

August 19, 2010

BioMarin Pharmaceutical has acquired privately owned biotechnology company ZyStor Therapeutics for $22 million, BioMarin said....

August 15, 2010

A lot of generic drug companies have conducted business in the branded drug market on...

August 12, 2010

Emergent BioSolutions will acquire Trubion Pharmaceuticals for $96.8 million upfront, under a deal the two...

August 2, 2010

Hospira had net sales of $968 million and profits of $83.5 million in second quarter...

July 21, 2010

Several generic drug makers have settled with Forest Labs and German drug maker Merz Pharma...

July 20, 2010

Biosimilars may have cleared their biggest stretch of wilderness thanks to their inclusion in the...

July 18, 2010

Biotechnology company Spectrum Pharmaceuticals has appointed a new SVP, chief scientific officer and head of...

July 14, 2010

Watson Pharmaceuticals will work with a venture-backed firm to develop a biosimilar treatment for female...

June 27, 2010

The Food and Drug Administrations has approved two new uses for what remains, thus far,...